An interventional study of Cervicocranial ultrasound-guided pharmacopuncture and Oriental medicine integrated treatment in Pharmacologic Action, sponsored by Jaseng Medical Foundation. Recruiting at 1 site in South Korea. Open to participants aged 19 Years to 69 Years. Per ClinicalTrials.gov, last updated 2026-10-26.
Sponsored by Jaseng Medical Foundation · Not applicable, Interventional, and Treatment
The purpose of this study is to reveal the effectiveness and safety of ultrasound-guided pharmacopuncture for patients with tension-type headache caused by a traffic accident. It is a pragmatic clinical study to confirm the comparative effectiveness by comparing the strategy of combining ultrasound-guided pharmacopuncture in parallel with the strategy of treating with integrative Korean medicine treatment, which is an existing treatment method.
Jaseng Medical Foundation is the lead sponsor of 69 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
20 patients in the Cervicocranial ultrasound-guided pharmacoapuncture
Procedure: Cervicocranial ultrasound-guided pharmacopuncture
20 patients in the Oriental medicine integrated treatment group
Procedure: Oriental medicine integrated treatment
Integrative Korean medicine treatment combined with cervicocranial ultrasound-guided pharmacopuncture. The physician chooses the adequate type and dose of pharmacopuncture, needle type, and target anatomical structures under ultrasound guidance.
Also known as: Drug: Herbal extract-based pharmacopuncture
Conventional integrative Korean medicine treatment comprising acupuncture, herbal medicine, pharmacopuncture, Chuna manual therapy, and other modalities (cupping, moxibustion, etc.). The physician selects the appropriate combination of treatments based on clinical judgment.
Also known as: Device: Acupuncture needles, herbal medicine, non-ultrasound guided pharmacopuncture, Chuna manual therapy, cupping devices, and moxibustion devices, etc.
Headache numeric rating scale (NRS)
The intensity of Headache will be assessed using the NRS. In the NRS, participants choose a number from 0 to 10 that best describes participant's comfort (0 being no pain and 10 being the most comfortable they can imagine).
Time frame: through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date
Neck pain numeric rating scale (NRS)
The intensity of Neck pain will be assessed using the NRS. In the NRS, participants choose a number from 0 to 10 that best describes participant's comfort (0 being no pain and 10 being the most comfortable they can imagine).
Time frame: through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date
Headache Disability Index (HDI)
The physical and emotional disability experienced by participants due to headache will be assessed to evaluate changes before and after treatment. It consists of a total of 25 items, with each item following the standardized scoring method of the original questionnaire tool (Yes = 4 points, Sometimes = 2 points, No = 0 points). The total score obtained through the survey reflects the degree of daily life restriction and quality of life due to headache, with higher scores indicating a greater degree of disability.
Time frame: through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date
Headache Impact Test (HIT-6)
The functional status and impact of headache on daily life will be assessed using the Headache Impact Test-6 (HIT-6). The HIT-6 is a 6-item questionnaire, with each item scored on a 5-point scale (Never = 6, Rarely = 8, Sometimes = 10, Very often = 11, Always = 13). The total score ranges from 36 to 78, where 36 indicates little to no impact and 78 indicates severe impact. A higher score indicates a worse outcome (greater headache severity and functional disability).
Time frame: through admission completion, an average of 2week, 4 weeks and 8 weeks after admission date
EuroQol-5 Dimension (EQ-5D-5L)
EQ-5D-5L is a method of evaluating health status from various aspects and then indirectly calculating the quality weight of a specific health status using pre-assigned preference scores for each functional level. It is the most widely used among several indirect measurement methods. there is. The EQ-5D-5L consists of 5 questions. Each question includes mobility, self-care, usual activities, pain/discomfort, and anxiety/depression ( Ask about the level of anxiety/depression, etc. Weights are assigned according to the level of each item, and the preference score calculation equation is presented based on these weights and constants.
Time frame: Enrollment date, 2, 4 and 8 weeks after admission date
Patient Global Impression of Change (PGIC)
This is a method that allows participants to subjectively evaluate the degree of improvement on a 7-level scale: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse.
Time frame: 8days, 2, 4, 8 weeks after admission date
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Dec 2027, 14 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jaseng Medical Foundation